The complaint filed against the NASDAQ-listed firm targets violations of the Securities Exchange Act of 1934. According to the suit, PROCEPT BioRobotics utilized aggressive discounting strategies to pull sales from future periods into the present, effectively masking the company’s true financial health. Plaintiffs argue these actions rendered public statements issued throughout the class period materially misleading.

Investors who purchased PRCT shares during the window of February 28, 2024, to February 25, 2026, are eligible to join the litigation. The DJS Law Group, which is spearheading the effort, has set a September 22, 2026, deadline for those seeking to participate in the recovery process. While the firm encourages contact regarding lead plaintiff appointments, participation in the eventual recovery does not strictly mandate such a role.